Fig. 8

In situ host T-cell programming via PEGDA–PLL implants leads to Th1 and Th17-based responses. Quantification of Th1 cytokines (a) and Th17 cytokines (b) levels in serum analyzed using multiplexing. ^*P < 0.05, ^**P < 0.01, ^***P < 0.001, one-way ANOVA with Tukey’s test. OVA ovalbumin, PEGDA–PLL polyethylene glycol diacrylate poly-L-lysine, BLV bolus lentiviruses, SLV scaffold loaded lentiviruses, IL-2 interleukin-2, IFN-γ interferon-γ, TNF-ɑ tumor necrosis factor-ɑ, IL-17A interleukin-17A, IL-21 interleukin-21, IL-22 interleukin 22